ArticleOncoTargets and therapy2019

Clinical efficacy of decitabine in combination with standard-dose cytarabine, aclarubicin hydrochloride, and granulocyte colony-stimulating factor in the treatment of young patients with newly diagnosed acute myeloid leukemia.

Liping Dou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.